306 related articles for article (PubMed ID: 25204045)
1. Role of anti-nucleosome antibodies in the diagnosis of systemic lupus erythematosus and as a marker for lupus nephropathy.
Abdel Gawad ER; Mansour AI; Abdel Aziz YA; Soliman AF; Fawzy RM
Egypt J Immunol; 2014; 21(1):57-65. PubMed ID: 25204045
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies.
Gutiérrez-Adrianzén OA; Koutouzov S; Mota RM; das Chagas Medeiros MM; Bach JF; de Holanda Campos H
J Rheumatol; 2006 Aug; 33(8):1538-44. PubMed ID: 16783863
[TBL] [Abstract][Full Text] [Related]
3. Anti-nucleosome antibodies in patients with systemic lupus erythematosus: potential utility as a diagnostic tool and disease activity marker and its comparison with anti-dsDNA antibody.
Saigal R; Goyal LK; Agrawal A; Mehta A; Mittal P; Yadav RN; Meena PD; Wadhvani D
J Assoc Physicians India; 2013 Jun; 61(6):372-7. PubMed ID: 24640201
[TBL] [Abstract][Full Text] [Related]
4. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
5. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of anti-dsDNA antibody isotypes: IgG/IgM ratio of anti-dsDNA antibodies as a prognostic marker for lupus nephritis.
Förger F; Matthias T; Oppermann M; Becker H; Helmke K
Lupus; 2004; 13(1):36-44. PubMed ID: 14870916
[TBL] [Abstract][Full Text] [Related]
7. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
[TBL] [Abstract][Full Text] [Related]
8. [The role of anti-nucleosome antibodies in systemic lupus erythematosus. Results of a study of patients with systemic lupus erythematosus and other connective tissue diseases].
Quattrocchi P; Barrile A; Bonanno D; Giannetto L; Patafi M; Tigano V; Ferlazzo B
Reumatismo; 2005; 57(2):109-13. PubMed ID: 15983634
[TBL] [Abstract][Full Text] [Related]
9. Anti-dsDNA, anti-nucleosome and anti-C1q antibodies as disease activity markers in patients with systemic lupus erythematosus.
Zivković V; Stanković A; Cvetković T; Mitić B; Kostić S; Nedović J; Stamenković B
Srp Arh Celok Lek; 2014; 142(7-8):431-6. PubMed ID: 25233687
[TBL] [Abstract][Full Text] [Related]
10. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
[TBL] [Abstract][Full Text] [Related]
11. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
[TBL] [Abstract][Full Text] [Related]
12. Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus.
Tydén H; Lood C; Gullstrand B; Jönsen A; Ivars F; Leanderson T; Bengtsson AA
Lupus; 2017 Feb; 26(2):139-149. PubMed ID: 27407135
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
14. Role of anti-nucleosome antibody in the diagnosis of systemic lupus erythematosus.
Su Y; Jia RL; Han L; Li ZG
Clin Immunol; 2007 Jan; 122(1):115-20. PubMed ID: 17085075
[TBL] [Abstract][Full Text] [Related]
15. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
Amoura Z; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
[TBL] [Abstract][Full Text] [Related]
16. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
Orjuela A; Suwanichkul A; Canter D; Minard CG; Devaraj S; Hicks MJ; Muscal E; Wenderfer SE
Am J Nephrol; 2015; 41(3):241-7. PubMed ID: 25926050
[TBL] [Abstract][Full Text] [Related]
17. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
Jaekell HP; Trabandt A; Grobe N; Werle E
Lupus; 2006; 15(6):335-45. PubMed ID: 16830879
[TBL] [Abstract][Full Text] [Related]
18. An analysis of clinical disease activity and nephritis-associated serum autoantibody profiles in patients with systemic lupus erythematosus: a cross-sectional study.
Ravirajan CT; Rowse L; MacGowan JR; Isenberg DA
Rheumatology (Oxford); 2001 Dec; 40(12):1405-12. PubMed ID: 11752513
[TBL] [Abstract][Full Text] [Related]
19. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
Pradhan VD; Patwardhan MM; Ghosh K
Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
[TBL] [Abstract][Full Text] [Related]
20. Anti-nucleosome, anti-chromatin, anti-dsDNA and anti-histone antibody reactivity in systemic lupus erythematosus.
González C; Garcia-Berrocal B; Herráez O; Navajo JA; González-Buitrago JM
Clin Chem Lab Med; 2004 Mar; 42(3):266-72. PubMed ID: 15080558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
